Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review

Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review

In clinical use, bevacizumab has improved the overall survival (OS) and progression-free survival (PFS) of malignant solid tumors, and the safe use of bevacizumab has gradually become the mainstream direction of clinical, nursing and pharmaceutical research. Bevacizumab is a humanized anti-VEGF drug...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ke Chen, Boyang Jiang, Huiping Yan, Liu Yang, Zheling Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Oncology
Subjects:	bevacizumab adverts effects VEGF cerebrovascular accident cancer case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1395129/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis
by: Jie Dai, et al.
Published: (2025-01-01)

Severe late onset capillary leak syndrome post allo-HSCT successfully treated by bevacizumab: a case report
by: Song Xue, et al.
Published: (2025-01-01)

Comparison of reactivation between ranibizumab and bevacizumab in aggressive retinopathy of prematurity: A retrospective case series
by: Anil Babanrao Gangwe, et al.
Published: (2025-01-01)

Cerebrovascular Accidents After Orthotopic Liver Transplantation in Patients with Hepatopulmonary Syndrome: A Case Series
by: Steffi K. Chan, et al.
Published: (2024-12-01)

SUCCESSFUL REGISTRATION OF DOMESTIC BIOANALOGUE OF BEVACIZUMAB – NEW OPPORTUNITIES FOR EFFECTIVE TREA TMENT OF PATIENTS WITH NON-SQUAMOUS CELL NON-SMALL CELL LUNG CANCER
by: S. V. Orlov, et al.
Published: (2016-01-01)

Three effective cases of transcatheter arterial embolization after atezolizumab and bevacizumab treatment for hepatocellular carcinoma: a case report
by: Koji Rinka, et al.
Published: (2025-01-01)

To evaluate the efficacy of subconjunctival bevacizumab injection in vascular pterygium before surgical excision in preventing recurrence comparing with bare sclera technique
by: Nusrat Shaheen, et al.
Published: (2025-01-01)

Efficacy of Sub-Conjunctival Injection of Mitomycin C Versus Bevacizumab in Pterygium Treatment: Pakistani Population
by: Amber khalid, et al.
Published: (2025-01-01)

Early postoperative bevacizumab for preventing neovascular glaucoma in phacovitrectomy for proliferative diabetic retinopathy
by: Sunjin Hwang, et al.
Published: (2025-01-01)

Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy
by: Hironori Ochi, et al.
Published: (2025-01-01)

Clinic Practical Guides for Cerebrovascular Diseases
by: Miguel Angel Buergo Zuaznábar, et al.
Published: (2007-05-01)

Complications and Mortality Characterization in Acute Ischemic Cerebrovascular Disease
by: Ricardo Leyva Tornés, et al.
Published: (2021-09-01)

Association Between Blood Pressure Variation During Dialysis and Cardio‐Cerebrovascular Events
by: Zhenliang Fan, et al.
Published: (2025-01-01)

Examining the therapeutic potential and side effects of calcium channel blockers in mortality and morbidity of patients with stroke: A systematic review of pre-clinical and clinical studies
by: Sevak Hatamian, et al.
Published: (2025-06-01)

Investigation of the effect of intravitreal bevacizumab treatment on left heart function using speckle tracking echocardiography
by: Mehmet Şahinbaş, et al.
Published: (2025-01-01)

The Cerebrovascular Disease and Nutritional State.
by: Leticia del Rosario Cruz, et al.
Published: (2007-05-01)

Intra-operative Intravitreal Bevacizumab For Patients With Diabetic Macular Edema Undergoing Phacoemulsification with Foldable IOL Implantation
by: Haider Ali Chaudhry, et al.
Published: (2024-06-01)

Evaluation of the association between bevacizumab concentration and clinical outcomes in patients with breast cancer brain metastasis
by: Chih-Ning Cheng, et al.
Published: (2025-01-01)

Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan
by: Jaekyung Cheon, et al.
Published: (2025-01-01)

Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
by: Parissa Tabrizian, et al.
Published: (2025-02-01)

When Stroke Disguises as Dementia: A Case of Missed Cerebral Venous Thrombosis
by: Tina Moghadam Fard, et al.
Published: (2025-01-01)

Cerebrovascular illness in the province of Cienfuegos. Tendency lines. A six years study
by: Rubén Bembibre Taboada, et al.
Published: (2006-08-01)

Comorbidities, long‐term outcome and poststroke epilepsy associated with ischemic stroke – A multicenter observational study of 125 dogs
by: Cecilia‐Gabriella Danciu, et al.
Published: (2025-01-01)

Caracterización clínica de pacientes fallecidos por enfermedad cerebrovascular
by: Leonardo Javier Pérez Ponce, et al.
Published: (2019-09-01)

Risk Factors Associated with Cerebrovascular Diseases in Patients at the Tulcán Sur Health Center
by: María Verónica Aveiga Hidalgo, et al.
Published: (2024-04-01)

The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naïve primary stage IVB cervical cancer
by: Junhwan Kim, et al.
Published: (2025-01-01)

Fundamentals of Graphic Art /
by: Apollo,Baker
Published: (2010)

Left ventricular clot mysteries: A case report of vanishing left ventricular clot and role of multimodality imaging in a patient presenting with ischemic cerebrovascular stroke
by: Susheel K. Malani, et al.
Published: (2024-12-01)

Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
by: Meng Wu, et al.
Published: (2025-02-01)

Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
by: Carmine Pinto, et al.
Published: (2025-01-01)

Characterization of patients with ischemic cerebrovascular disease and cognitive impairment. Cienfuegos, 2018
by: Beatriz Perdomo Borges, et al.
Published: (2020-05-01)

IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG?
by: S. V. Orlov, et al.
Published: (2016-06-01)

TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis
by: Ritam Joarder, et al.

Renal impairment as a risk factor for chemotherapy induced neutropenia in the treatment of trifluridine/thymidine phosphorylase inhibitor plus bevacizumab
by: Masatsune Shibutani, et al.
Published: (2025-01-01)

Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
by: Hossein Ashraf, et al.
Published: (2025-06-01)

Letalidad hospitalaria por enfermedad cerebrovascular en la provincia de Cienfuegos
by: Ada Sánchez Lozano, et al.
Published: (2014-12-01)

The efficacy and safety of indobufen in patients with ischemic cardiovascular or cerebrovascular diseases: systematic review and meta-analysis
by: Xiaolu Luo, et al.
Published: (2025-01-01)

Anti-phospholipid Sindrome. A case report
by: José M. Carles Zerquera, et al.
Published: (2007-04-01)

Cerebrovascular Diseases and Risk Factors: a Strategy of Primary Prevention
by: Miguel Angel Buergo Zuaznábar, et al.
Published: (2007-05-01)

Efficacy and safety of neoadjuvant bevacizumab plus chemotherapy in locally advanced gastric cancer patients: a retrospective, comparative study
by: Bin Yin, et al.
Published: (2025-01-01)